28 related articles for article (PubMed ID: 33983670)
1. Performance of capecitabine in novel combination therapies in colorectal cancer.
Pouya FD; Rasmi Y; Camci IY; Tutar Y; Nemati M
J Chemother; 2021 Oct; 33(6):375-389. PubMed ID: 34019782
[TBL] [Abstract][Full Text] [Related]
2. Interaction between CD9 and PI3K‑p85 activates the PI3K/AKT signaling pathway in B‑lineage acute lymphoblastic leukemia.
Shi YF; Huang ZY; Huang YS; Dong RJ; Xing CY; Yu K; Leung KT; Feng JH
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036396
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities.
Li Z; Zhao H; Wang J
Front Cardiovasc Med; 2021; 8():650278. PubMed ID: 34026868
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone and thyroid hormone nuclear receptors: History and present state of art.
Brtko J
Endocr Regul; 2021 May; 55(2):103-119. PubMed ID: 34020531
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration.
Aboushoushah S; Alshammari W; Darwesh R; Elbaily N
Life Sci; 2021 Jul; 277():119625. PubMed ID: 34015288
[TBL] [Abstract][Full Text] [Related]
6. Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells.
Chiu YJ; Tsai FJ; Bau DT; Chang LC; Hsieh MT; Lu CC; Kuo SC; Yang JS
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013378
[TBL] [Abstract][Full Text] [Related]
7. Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug.
Nesti L; Tricò D; Mengozzi A; Natali A
Cardiovasc Diabetol; 2021 May; 20(1):109. PubMed ID: 34006325
[TBL] [Abstract][Full Text] [Related]
8. Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level.
Zhang N; Gao M; Wang Z; Zhang J; Cui W; Li J; Zhu X; Zhang H; Yang DH; Xu X
J Pharm Biomed Anal; 2021 Jul; 201():114129. PubMed ID: 34000577
[TBL] [Abstract][Full Text] [Related]
9. New approaches to targeting the androgen receptor pathway in prostate cancer.
Velho PI; Bastos DA; Antonarakis ES
Clin Adv Hematol Oncol; 2021 Apr; 19(4):228-240. PubMed ID: 33989272
[TBL] [Abstract][Full Text] [Related]
10. Potent and Selective Benzothiazole-Based Antimitotics with Improved Water Solubility: Design, Synthesis, and Evaluation as Novel Anticancer Agents.
Gallego-Yerga L; Ceña V; Peláez R
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376146
[TBL] [Abstract][Full Text] [Related]
11. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in microtubule-stabilizing agents.
Cao YN; Zheng LL; Wang D; Liang XX; Gao F; Zhou XL
Eur J Med Chem; 2018 Jan; 143():806-828. PubMed ID: 29223097
[TBL] [Abstract][Full Text] [Related]
13. Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach.
Rana A; Bhatnagar S
Bioorg Chem; 2021 Jul; 112():104946. PubMed ID: 33989916
[TBL] [Abstract][Full Text] [Related]
14. A Small Molecule with Bridged Carbonyl and Tri-fluoro-aceto-phenone Groups Impedes Microtubule Dynamics and Subsequently Triggers Cancer Cell Apoptosis.
Mohapatra S; Gupta V; Mondal P; Chatterjee S; Bhunia D; Ghosh S
ChemMedChem; 2021 Sep; 16(17):2703-2714. PubMed ID: 33983670
[TBL] [Abstract][Full Text] [Related]
15. Ligand- and structural-based discovery of potential small molecules that target the colchicine site of tubulin for cancer treatment.
Guo Q; Zhang H; Deng Y; Zhai S; Jiang Z; Zhu D; Wang L
Eur J Med Chem; 2020 Jun; 196():112328. PubMed ID: 32320841
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
